Selecta Biosciences is a clinical-stage biopharmaceutical company developing targeted immunotherapies and vaccines that are designed to modulate immune responses to treat and prevent disease. Selecta’s proprietary Synthetic Vaccine Particle (SVP™) platform has the potential to create a new paradigm in immunology and may enable a novel approach for selectively targeting the immune system to effectively and safely treat and prevent rare and serious diseases.
Looking for a particular Selecta Biosciences employee's phone or email?
The Selecta Biosciences annual revenue was $7.3 million in 2026.
Sheldon Leung is the Sr. Director, Translational Biology and Bioanalytical of Selecta Biosciences.
4 people are employed at Selecta Biosciences.
Selecta Biosciences is based in Watertown, Massachusetts.
The NAICS codes for Selecta Biosciences are [541, 54, 32, 325, 3254, 32541].
The SIC codes for Selecta Biosciences are [87, 873].